0000874015-21-000037.txt : 20210120
0000874015-21-000037.hdr.sgml : 20210120
20210120190446
ACCESSION NUMBER: 0000874015-21-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOUGEN ELIZABETH L
CENTRAL INDEX KEY: 0001074773
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 21539997
MAIL ADDRESS:
STREET 1: 10070 BARNES CANYON ROAD
STREET 2: C/O MOLECULAR BIOSYSTEMS INC
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-01-15
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001074773
HOUGEN ELIZABETH L
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE CT.
CARLSBAD,
CA
92010
0
1
0
0
EVP, Finance & CFO
Common Stock
2021-01-15
2021-01-15
4
M
0
17151
0
A
49646
D
Common Stock
2021-01-15
2021-01-15
4
F
0
6175
61.28
D
43471
D
Restricted Stock Units
2021-01-15
2021-01-15
4
A
0
27129
0
A
Common Stock
27129
27129
D
Restricted Stock Units
2021-01-15
2021-01-15
4
M
0
17151
0
D
Common Stock
17151
34199
D
Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards.
Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Restricted Stock Units vest in four equal monthly installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis.
/s/Patrick R. O'Neil, attorney-in-fact
2021-01-20